Bonjour ,
Bienvenue sur votre profil personnel. Votre carte de visite professionnelle présente votre activité principale. Elle sera visible sur EuroQuity.
% complété
%
2 Ce profil est validé par 2 label.
Company
Protinhi Therapeutics
29
EQ SCORE L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.
We are an early-stage biotech company aiming to combat (emerging) viral infectious diseases with a high unmet medical need. With our proprietary technology, we are developing novel antiviral drugs that inhibit proteases and block viral replication.
Nijmegen, Gelderland, Netherlands
Send a message
Anglais
Protinhi Therapeutics
Anglais
Protinhi Therapeutics develops novel drugs acting as protease inhibitors to treat a wide range of illnesses. Currently we focus on viral infectious diseases, including Flaviviridae (e.g., dengue), Chikungunya and Corona virus. Our aim is to make those drugs available as new medication for patients in need of effective treatment.
In viral infectious diseases, protease encoded by virus plays a crutial role in its viral replication after infection of host cells. Protinhi’s innovative...
Protinhi Therapeutics develops novel drugs acting as protease inhibitors to treat a wide range of illnesses. Currently we focus on viral infectious diseases, including Flaviviridae (e.g., dengue), Chikungunya and Corona virus. Our aim is to make those drugs available as new medication for patients in need of effective treatment.
In viral infectious diseases, protease encoded by virus plays a crutial role in its viral replication after infection of host cells. Protinhi’s innovative compounds are inhibitory small molecules which block the protease, and consequentially also the mediated viral replication. The ability to block viral replication empowers our small molecules to be drug candidates not only for therapeutic treatment but also for prophylactic use.
Team member(s)
Your request has been sent
Board member(s)
Join this organization
Your request has been sent
Team member(s)
Board member(s)
Our network
Your request has been sent
Join this network
Your message has been sent
Certifications
The Seal of Excellence is a quality label awarded to project proposals submitted to Horizon 2020 which succeeded a highly competitive evaluation process by independent experts, but did not receive funding due to budget limits.
This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential.
1482 Entities
Eureka is the world’s leading network for international R&D collaborations, represented in over 45 countries.
It aims to boost the growth of SMEs, large companies, research organisations and universities through funding and supporting international R&D cooperation and providing investment-readiness services
Through Eureka’s programmes, organisations can access funding and expert support. The Eureka label is given to companies who have been financed through Eureka programmes.
215 Entities
Communities
InvestHorizon is an accelerator programme designed to facilitate the access to Series A funding
for selected DEEP TECH companies.
2672 Members
Access2EIC is a 7-year coordination and support action which builds upon the foundations laid by previous EIC support networks and in line with the new Horizon Europe Framework Programme.
The Access2EIC Community aims to support the best European companies in "transition" stage.
https://access2eic.eu/
2141 Members